GAB1 and breast carcinoma: GAB1 expression appears to be deregulated in a wide variety of tumors such as thyroid cancer, cervical cancer, breast cancer, meningiomas, cholangiocarcinoma, medulloblastomas, chronic lymphocytic leukemia, head and neck cancer, and colorectal cancer, among others (Figure 4).